Mesoblast MESO
NASDAQ MESO
$17.32 +0.18 (+1.05%)
At close: Sep 4, 2026 · 4:00 PM EDT

Mesoblast (MESO) Change in Account Payables (2014 - 2024)

Mesoblast (MESO) posted Change in Account Payables of -$2.0 million for Q1 2023, down 140.09% sequentially from $5.0 million in Q4 2022, and down 40.36% YoY from -$3.4 million in Q1 2022.

Analysis

Mesoblast (MESO) Change in Account Payables (2014 - 2024) Analysis & Trends

Mesoblast has reported Change in Account Payables for 8 years, with the latest figure at -$2.0 million in Q1 2023.

  • Quarterly Change in Account Payables fell 40.36% year-over-year to -$2.0 million in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $4.7 million (up 222.13% YoY) and the FY2022 annual result came in at $4.8 million, up 194.39% from the prior year.
  • Change in Account Payables declined to -$2.0 million in Q1 2023 per MESO's latest filing, from $5.0 million in the prior quarter.
  • Over five years, Change in Account Payables peaked at $6.2 million in Q4 2019 and troughed at -$7.3 million in Q1 2019.
  • A 5-year average of -$501411.8 and a median of -$1.4 million in 2022 frame the typical range for Change in Account Payables.
  • The widest YoY moves for Change in Account Payables: up 1346.12% in 2021, down 1022.58% in 2021.
  • Over 5 years, Change in Account Payables stood at $6.2 million in 2019, then slumped by 106.63% to -$412000.0 in 2020, then surged by 1346.12% to $5.1 million in 2021, then declined by 2.69% to $5.0 million in 2022, then plunged by 140.09% to -$2.0 million in 2023.
  • According to Business Quant data, Change in Account Payables over the past three periods registered -$2.0 million, $5.0 million, and -$2.4 million for Q1 2023, Q4 2022, and Q3 2022 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -8.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 5.03 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 37.53 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Mesoblast 2.24 Bn 2.14 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -12.38 Mn
Jun 30, 2023 -398,000.00
Mar 31, 2023 -2.00 Mn
Dec 31, 2022 5.00 Mn
Sep 30, 2022 -2.39 Mn
Jun 30, 2022 4.09 Mn
Mar 31, 2022 -1.43 Mn
Dec 31, 2021 5.13 Mn
Sep 30, 2021 -3.02 Mn
Jun 30, 2021 -4.53 Mn
Mar 31, 2021 -3.72 Mn
Dec 31, 2020 -412,000.00
Sep 30, 2020 3.60 Mn
Mar 31, 2020 6.31 Mn
Dec 31, 2019 5.91 Mn
Sep 30, 2019 -300,000.00
Mar 31, 2019 -7.34 Mn
Dec 31, 2018 8.77 Mn
Sep 30, 2018 2.19 Mn
Jun 30, 2018 -2.92 Mn